IPad 2
iPad 2 is a tablet computer developed by Apple Inc. It is the second generation of the iPad line and was announced on March 2, 2011, by then-CEO Steve Jobs. The iPad 2 was released in the United States on March 11, 2011, and later rolled out to other countries. It built upon the original iPad's features with a slimmer design, faster processor, and improved graphics capabilities.
Design and Features[edit | edit source]
The iPad 2 features a 9.7-inch (diagonal) LED-backlit Multi-Touch display with IPS technology, offering a resolution of 1024x768 pixels at 132 pixels per inch (ppi). It is powered by a dual-core Apple A5 processor, enhancing its performance over its predecessor. The device comes in two variants: Wi-Fi only and Wi-Fi + 3G, with the latter offering cellular connectivity. It introduced cameras to the iPad line, featuring a front-facing VGA camera for FaceTime and video calling, and a rear-facing camera capable of recording 720p video.
The iPad 2's design is notably thinner and lighter than the original iPad. It measures 0.34 inch (8.8 mm) in thickness and weighs 1.33 pounds (601 grams) for the Wi-Fi model and 1.35 pounds (613 grams) for the Wi-Fi + 3G model. The device was available in black and white color options.
Software[edit | edit source]
The iPad 2 originally shipped with iOS 4.3, introducing several new features, including AirPlay mirroring and improvements to the Safari web browser. Over its lifespan, the iPad 2 received multiple iOS updates, with its final supported version being iOS 9.3.5. This extended software support period is notable, as it allowed the iPad 2 to receive updates for over five years after its release.
Reception[edit | edit source]
Upon its release, the iPad 2 received widespread acclaim for its design, improved performance, and battery life, maintaining Apple's position in the tablet market. Critics praised its thin profile and the addition of cameras, though some noted that the cameras' quality was not as high as expected.
Legacy[edit | edit source]
The iPad 2 is considered a pivotal device in the tablet industry, setting standards for future devices in terms of design and functionality. It remained in production until March 2014, making it one of the longest-produced iPads, which is a testament to its enduring popularity.
See Also[edit | edit source]
IPad 2 Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD